The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial. - O'Donnell P; Dong C; Murthy V; Asgharnejad M; Du X; Summerfelt A; Lu H; Xu L; Wendland JR; Dunayevich E; Buhl DL; Litman R; et al. (Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023)